![Helmut Kessmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Helmut Kessmann
Direktor/Vorstandsmitglied bei
Swiss Healthcare Licensing Group
Profil
Helmut H.
Kessmann was the founder of Discovery Technologies Ltd, founded in 1996, and T3 Pharmaceuticals AG, founded in 2015, where the title of Director was held.
The current job is Director at Swiss Healthcare Licensing Group since 2018.
Former jobs include Principal at Ciba-Geigy AG, Chief Business Officer at Graffinity Pharmaceuticals AG, Chief Business Officer at Santhera Pharmaceuticals Holding AG from 2010 to 2011, and Head-Business Development at Spexis Ltd. from 2011 to 2019.
Education includes a doctorate from the University of Münster, conferred in 1988.
Aktive Positionen von Helmut Kessmann
| Unternehmen | Position | Beginn |
|---|---|---|
Swiss Healthcare Licensing Group
 Swiss Healthcare Licensing Group Founded in 2002, Swiss Healthcare Licensing Group is a non-profit industry association dedicated to healthcare business development and licensing within the life sciences and healthcare sectors. The private company is based in Basel, Switzerland. The organization supports emerging biopharma start-ups through initiatives such as workshops on pitching, negotiation, and valuation, developed in partnership with companies like Johnson & Johnson and BaseLaunch. It organizes an annual flagship conference, multiple networking events, and educational webinars. Swiss Healthcare Licensing Group promotes transparent, ethical, and effective partnerships in healthcare licensing through its Good Partnering Practices (GPP) framework, which includes educational resources for professionals. | Direktor/Vorstandsmitglied | 01.02.2018 |
Ehemalige bekannte Positionen von Helmut Kessmann
| Unternehmen | Position | Ende |
|---|---|---|
| SPEXIS AG | Corporate Officer/Principal | 01.12.2019 |
| SANTHERA PHARMACEUTICALS HOLDING AG | Corporate Officer/Principal | 31.10.2011 |
T3 Pharmaceuticals AG
 T3 Pharmaceuticals AG BiotechnologyHealth Technology Develops bacterial cancer therapies and medicines | Gründer | - |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
Graffinity Pharmaceuticals AG
 Graffinity Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Specializes in chemical genomics pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Helmut Kessmann
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Discovery Technologies Ltd
 Discovery Technologies Ltd Miscellaneous Commercial ServicesCommercial Services Provides high output screening capabilities, customized assay development/optimization, and chemical libraries | Commercial Services |
Graffinity Pharmaceuticals AG
Graffinity Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Specializes in chemical genomics pharmaceutical products | Health Technology |
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
University of Münster
 University of Münster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spexis Ltd.
 Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
Swiss Healthcare Licensing Group
Swiss Healthcare Licensing Group Founded in 2002, Swiss Healthcare Licensing Group is a non-profit industry association dedicated to healthcare business development and licensing within the life sciences and healthcare sectors. The private company is based in Basel, Switzerland. The organization supports emerging biopharma start-ups through initiatives such as workshops on pitching, negotiation, and valuation, developed in partnership with companies like Johnson & Johnson and BaseLaunch. It organizes an annual flagship conference, multiple networking events, and educational webinars. Swiss Healthcare Licensing Group promotes transparent, ethical, and effective partnerships in healthcare licensing through its Good Partnering Practices (GPP) framework, which includes educational resources for professionals. | |
T3 Pharmaceuticals AG
T3 Pharmaceuticals AG BiotechnologyHealth Technology Develops bacterial cancer therapies and medicines | Health Technology |
